| Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort KB Gecse, BD Lovász, K Farkas, J Banai, L Bene, B Gasztonyi, ... Journal of Crohn's and Colitis 10 (2), 133-140, 2016 | 218 | 2016 |
| Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort L Gonczi, KB Gecse, Z Vegh, Z Kurti, M Rutka, K Farkas, PA Golovics, ... Inflammatory bowel diseases 23 (11), 1908-1915, 2017 | 58 | 2017 |
| T-cell subsets in rheumatoid arthritis patients on long-term anti-TNF or IL-6 receptor blocker therapy S Dulic, Z Vásárhelyi, F Sava, L Berta, B Szalay, G Toldi, L Kovács, ... Mediators of Inflammation 2017, 2017 | 55 | 2017 |
| The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study B Szalay, B Vásárhelyi, Á Cseh, T Tulassay, M Deák, L Kovács, A Balog Clinical Rheumatology 33, 175-185, 2014 | 49 | 2014 |
| Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy B Szalay, G Mészáros, A Cseh, L Acs, M Deák, L Kovács, B Vásárhelyi, ... Journal of Immunology Research 2012, 2012 | 43 | 2012 |
| Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus G Toldi, B Szalay, G Bekő, M Bocskai, M Deák, L Kovács, B Vásárhelyi, ... Biomarkers 17 (8), 758-763, 2012 | 37 | 2012 |
| Outcomes of patients with inflammatory bowel diseases switched from maintenance therapy with a biosimilar to Remicade A Ilias, L Gonczi, Z Kurti, PA Golovics, K Farkas, E Schafer, Z Szepes, ... Clinical Gastroenterology and Hepatology 17 (12), 2506-2513. e2, 2019 | 32 | 2019 |
| The impact of anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis S Dulic, Z Vasarhelyi, A Bajnok, B Szalay, G Toldi, L Kovacs, A Balog Pathobiology 85 (3), 201-210, 2018 | 32 | 2018 |
| Immune phenotype of children with newly diagnosed and gluten-free diet-treated celiac disease Á Cseh, B Vásárhelyi, B Szalay, K Molnár, D Nagy-Szakál, A Treszl, ... Digestive diseases and sciences 56, 792-798, 2011 | 28 | 2011 |
| Serum maternal hepcidin levels 3 days after delivery are higher compared to those measured at parturition B Gyarmati, E Szabó, B Szalay, N Czuczy, G Toldi, Á Cseh, B Vásárhelyi, ... Journal of Obstetrics and Gynaecology Research 37 (11), 1620-1624, 2011 | 27 | 2011 |
| Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia G Toldi, E Bíró, B Szalay, B Stenczer, A Molvarec, J Rigó Jr, B Vásárhelyi, ... Clinical chemistry and laboratory medicine 49 (11), 1873-1876, 2011 | 27 | 2011 |
| Immune phenotype in children with therapy-naïve remitted and relapsed Crohn’s disease A Cseh, B Vasarhelyi, K Molnar, B Szalay, P Svec, A Treszl, A Dezsofi, ... World journal of gastroenterology: WJG 16 (47), 6001, 2010 | 26 | 2010 |
| Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases L Gonczi, Z Kurti, M Rutka, Z Vegh, K Farkas, BD Lovasz, PA Golovics, ... BMC gastroenterology 17, 1-7, 2017 | 25 | 2017 |
| Effect of cigarette smoke and dexamethasone on Hsp72 system of alveolar epithelial cells K Gál, Á Cseh, B Szalay, K Rusai, Á Vannay, J Lukácsovits, U Heemann, ... Cell Stress and Chaperones 16 (4), 369-378, 2011 | 25 | 2011 |
| Regulatory T cells and T helper subsets in breast-fed infants with hematochezia caused by allergic colitis Á Cseh, K Molnár, P Pintér, B Szalay, B Szebeni, A Treszl, A Arató, ... Journal of pediatric gastroenterology and nutrition 51 (5), 675-677, 2010 | 24 | 2010 |
| Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis N Legány, G Toldi, JHW Distler, C Beyer, B Szalay, L Kovács, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (11), 1799-1805, 2015 | 23 | 2015 |
| Gender differences in serum and glucocorticoid regulated kinase-1 (SGK-1) expression during renal ischemia/reperfusion injury K Rusai, Á Prókai, B Szebeni, K Mészáros, A Fekete, B Szalay, Á Vannay, ... Cellular Physiology and Biochemistry 27 (6), 727-738, 2011 | 22 | 2011 |
| FoxP3+ regulatory T cells in childhood allergic rhinitis and asthma G Mészáros, B Szalay, G Toldi, G Mezei, L Tamási, B Vásárhelyi, ... Journal of investigational allergology & clinical immunology 19 (3), 238-240, 2009 | 21 | 2009 |
| PISA 2015 összefoglaló jelentés L Ostorics, B Szalay, I Szepesi, C Vadász Budapest: Oktatási Hivatal, 2016 | 18 | 2016 |
| Successful use of tocilizumab in a patient with rheumatoid arthritis following severe pancytopenia during etanercept therapy B Szalay, L Ács, B Vásárhelyi, L Kovács, A Balog JCR: Journal of Clinical Rheumatology 17 (7), 377-379, 2011 | 18 | 2011 |
